NAUT
Nautilus Biotechnology, Inc.
There isn't enough reported data to score NAUT yet.
NAUT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Weak |
NAUT's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
NAUT PE Valuation
NAUT has no meaningful PE right now: it lost money over the past year.
NAUT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect NAUT's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
NAUT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.46 | +$0.04 |
| Q2 2026 | -$0.45 | +$0.07 |
| Q1 2026 | -$0.46 | +$0.08 |
| Q4 2025 | -$0.47 | +$0.09 |
| Q3 2025 | -$0.50 | +$0.05 |
| Q2 2025 | -$0.52 | +$0.03 |
| Q1 2025 | -$0.54 | $0.00 |
| Q4 2024 | -$0.56 | -$0.05 |
NAUT is still losing money, but less than at its worst: $0.46 per share over the past year, against $0.56 at its worst in late 2024.
NAUT Quarterly Revenue
NAUT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.7M | -$3.3M |
| Q2 2026 | -$14.2M | -$434K |
| Q1 2026 | -$13.6M | +$546K |
| Q4 2025 | -$12.6M | +$1.9M |
| Q3 2025 | -$11.5M | +$2.4M |
| Q2 2025 | -$13.7M | +$2.2M |
| Q1 2025 | -$14.2M | +$2.8M |
| Q4 2024 | -$14.6M | -$250K |
NAUT has burned cash in almost every quarter: −$55M over the past year, against −$54M the year before.
NAUT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +102K shares |
| 1 year | +0.7% | +933K shares |
| 3 years | +1.8% | +2.3M shares |
| 5 years | +131% | +72.2M shares |
| Available history | +1670% | +120M shares |
NAUT has 127M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $88,992 |
NAUT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | 106.4x | High |
NAUT's net debt is more than 20 years of its operating earnings (EBITDA).
NAUT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.8 | Neutral |
| Stochastic | 62.2 | Neutral |
NAUT's weekly RSI is 56 (neutral) and its Stochastic is 62 (neutral).
NAUT PE vs Healthcare Sector
NAUT has no meaningful PE right now: it lost money over the past year.
NAUT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.23 | 6.7% above |
| 20 week MA | $1.62 | 47% above |
| 50 week MA | $2.10 | 13% above |
| 100 week MA | $1.60 | 49% above |
| 200 week MA | $2.17 | 9.7% above |
NAUT has climbed back above all five of its weekly moving averages, and it's now 9.7% above its 200-week average.
NAUT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.4 | $10.9 | +4.2% |
| 2021 | $10.9 | $6.04 | -44% |
| 2022 | $6.04 | $1.85 | -69% |
| 2023 | $1.85 | $2.99 | +62% |
| 2024 | $2.99 | $1.70 | -43% |
| 2025 | $1.70 | $1.98 | +16% |
| 2026 YTD | $1.98 | $2.38 | +20% |
NAUT has finished lower in three of the last six years. It's up 20% so far in 2026.